Generics - Research

Filter

Current filters:

Research

Popular Filters

1 to 25 of 74 results

Amerigen Pharma and Ningbo Menovo link up on generics for US market

27-08-2014

US generic drugmaker Amerigen Pharmaceuticals and China’s Ningbo Menovo Pharmaceutical have entered…

Amerigen PharmaceuticalsChinaGenericsNingbo MenovoProductionResearchUSA

Hospira’s Retacrit effective in chemotherapy-induced anemia

Hospira’s Retacrit effective in chemotherapy-induced anemia

24-07-2014

USA-based Hospira, a leading provider of generic injectable drugs and infusion technologies, announced…

BiosimilarsErythropoiesis-stimulating agentsGenericsHematologyHospiraInfusion technologiesResearchRetacritUSA

Cipla to invest £100 million in its UK subsidiary

Cipla to invest £100 million in its UK subsidiary

07-07-2014

Indian drugmaker Cipla has decided to make a significant investment in its UK subsidiary over the next…

CiplaFinancialGenericsMarkets & MarketingResearchUK

PhRMA slams US President’s claims that Budget invests in innovation

06-03-2014

Pharmaceutical Research and Manufacturers of America (PhRMA) president and chief executive John Castellani…

GenericsNorth AmericaPatentsPharmaceuticalPoliticsResearchUSA

Cadila net profit up by 82% in third-quarter

07-02-2014

Indian drugmaker Cadila Healthcare posted a net profit of 1.86 billion rupees ($29.7 million), for the…

BiosimilarsCadila PharmaceuticalsFinancialGenericsResearchZydus Cadila

Brazil’s ANVISA and ProGenericos sign cooperation agreement

Brazil’s ANVISA and ProGenericos sign cooperation agreement

18-12-2013

Brazil's National Health Surveillance Agency, ANVISA has signed a memorandum of technical and operational…

BiosimilarsBrazilGenericsRegulationResearchSouth America

Kissei and JCR conclude accord on biosimilar Aranesp

01-10-2013

Kissei Pharmaceutical and JCR Pharmaceuticals have announced the conclusion of a collaborative R&D agreement…

AmgenAranespAsia-PacificBiosimilarsGenericsJCR PharmaceuticalsKissei PharmaceuticalOncologyResearch

First biosimilar monoclonal antibody approved in Europe

10-09-2013

US injectables and infusion technologies firm Hospira (NYSE: HSP) says the European Commission has approved…

Anti-Arthritics/RheumaticsBiotechnologyCellTrionEuropeGenericsHospiraInflectraMerck & CoRemicadeResearch

Baxter and Coherus in up to $246 million deal for biosimilar etanercept

04-09-2013

US companies Baxter International (NYSE:BAX) and Coherus Biosciences have entered into an exclusive collaboration…

AmgenAnti-Arthritics/RheumaticsBaxter InternationalBiotechnologyCoherus BioSciencesEnbreletanerceptGenericsLicensingResearch

Teva to drop development of Nuvigil in bipolar 1 disorder

31-08-2013

Israel-based leading generics company Teva Pharmaceutical Industries (NYSE: TEVA) has released disappointing…

armodafinilCephalonGenericsNeurologicalNuvigilPharmaceuticalResearchTeva Pharmaceutical Industries

Phase III data support biosimilarity of BOW-015 to Remicade

29-08-2013

Privately-held US biotech firm EPIRUS Biopharmaceuticals, which is focused on the development and production…

Anti-Arthritics/RheumaticsBiotechnologyEPIRUS BiopharmaceuticalsGenericsinfliximabRegulationRemicadeResearch

Pharmstandard commits $30 million to Argos Therapeutics; post 1st-half results

28-08-2013

Russia's largest drugmaker Pharmstandard (PHST: RU) that its subsidiary Pharmstandard International.(Luxembourg)…

AGS-003Argos TherapeuticsFinancialGenericsOncologyPharmaceuticalPharmstandardResearch

BPH drug doesn't increase risk of death, but does save men from prostate cancer

15-08-2013

A long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy & Research…

finasterideGenericsMen's HealthMerck & CoOncologyPharmaceuticalProscarResearch

New lab hopes to attract Western pharma for preclinical studies in Russia

09-08-2013

One of Russia's largest laboratories for preclinical studies of drugs will soon be opened in the Vsevologsk…

Dom of PharmacyEuropeGenericsPharmaceuticalResearch

Strategic alliance for pharmaceutical contract research and manufacturing in China

07-08-2013

Taiwanese active pharmaceutical ingredients (APIs) maker ScinoPharm (Changshu) Pharmaceuticals (TSE:…

Asia-PacificGenericsProductionResearchScinoPharmSundai MediTech

US firms establish strategic partnership around biosimilars

06-08-2013

Privately-held Oncobiologics has formed a broad strategic partnership with fellow USA-based inVentiv…

AvastinBiotechnologyErbituxGenericsHerceptinHumiraImmunologicalsinVentive HealthOncobiologicsOncologyProductionResearchRituxan

Eternity and PharmaNova to develop branded medicines

18-07-2013

Canadian medical device company Eternity Healthcare (OTC:ETAH) has signed a letter of intent with privately-held…

Eternity HealthcareGenericsMetabolicsPharmaceuticalPharmaNovaResearch

Indian citizens lack free access to essential generic medicines, while policies risk undermining new drug research funding

17-07-2013

Modern India has the third largest national economy in the world in purchasing power adjusted terms.…

Asia-PacificFinancialGenericsHealthcarePatentsResearch

Indian pharma threatened by trend of shifting R&D operations overseas: survey

04-07-2013

Red tape is putting India's multi-billion dollar worth pharmaceutical industry at risk, with most of…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalRegulationResearch

Prescription painkiller overdoses has risen 400% in women, says the US CDC

03-07-2013

Women in the USA are dying from prescription painkiller overdoses at rates never seen before, according…

Endo Health SolutionsGenericsHealthcareMethadoneOpanaOxyContinPurdue PharmaResearchVicodinWomen's Health

Sandoz initiates Ph III trial for biosimilar Enbrel

24-06-2013

Swiss drug major Novartis' (NOVN: VX) generics unit Sandoz has initiated a major Phase III clinical trial…

AmgenAnti-Arthritics/RheumaticsBiotechnologyDermatologicalsEnbrelGenericsNovartisResearchSandoz

Generics triple-therapy just as effective as brand-name Enbrel, new study shows

13-06-2013

Global biotech leader Amgen's (Nasdaq: AMGN) branded drug Enbrel (etanercept) is no more effective in…

AmgenAnti-Arthritics/RheumaticsEnbrelGenericsmethotrexatePharmaceuticalResearch

Hospira's biosimilar epoetin meets primary endpoints in post-marketing study

04-06-2013

Leading provider of injectable drugs and infusion technologies Hospira (NYSE: HSP) says that results…

BiotechnologyepoetinGenericsOncologyResearchRetacrit

1 to 25 of 74 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top